Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other Non-Current Liabilities (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Other Non-Current Liabilities for 15 consecutive years, with $386000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 601.82% to $386000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $386000.0 through Dec 2025, up 601.82% year-over-year, with the annual reading at $386000.0 for FY2025, 601.82% up from the prior year.
  • Other Non-Current Liabilities hit $386000.0 in Q4 2025 for Perspective Therapeutics, up from $342000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $668000.0 in Q3 2023 to a low of $19000.0 in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $460166.7 across 5 years, with a median of $612000.0 in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 97.12% in 2024 and later skyrocketed 1394.74% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $624000.0 in 2021, then rose by 5.29% to $657000.0 in 2022, then increased by 1.67% to $668000.0 in 2023, then plummeted by 91.77% to $55000.0 in 2024, then skyrocketed by 601.82% to $386000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CATX at $386000.0 in Q4 2025, $342000.0 in Q3 2025, and $284000.0 in Q2 2025.